Anticancer Potential of Thiocolchicoside: An In-Vitro MTT Assay Study

Thiocolchicoside (THC), a semi-synthetic derivative of colchicoside, is utilized clinically as a muscle relaxant. Nonetheless, its structural resemblance to colchicine indicates possible anticancer attributes. This study sought to assess the cytotoxic effects of THC on human mammary gland breast adenocarcinoma (MCF-7) and human gastric adenocarcinoma (AGS) cell lines utilizing the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, in comparison to VC. Cells were exposed to incremental dosages of THC 20-100 µg/ml and VC 20-100 µg/ml for 24 to 48 hours, and cell viability was evaluated. THC showed dose‑dependent cytotoxicity, reducing cell viability at higher concentrations, though less potent than VC. These results suggest that THC may have anticancer properties, necessitating more mechanistic and in vivo investigations. The aim was to study the anticancer effects of THC in various cell lines in comparison with the standard drug VC. The MCF-7 and AGS cell lines, which were chosen as exemplary models for the investigation, were procured from the National Centre of Cell Sciences (NCCS), Pune, India. Dimethyl Sulfoxide (DMSO), 200 µl, which was used as a control in this study, was procured from Thermo Fisher, Pune, India. THC was used as a test drug and was procured from Dr. Reddy's Laboratory Limited, Hyderabad, India, and VC, which was used as a reference drug, was procured from Yarrow Chem Products, Mumbai, India. The MTT reagent used in this study to monitor cell viability was procured from Thermo Fisher Scientific, Pune, India. Cell lines were treated with different concentrations of THC and VC ranging from 20 to 100 µg/ml for 24-48 hours, and absorbance was measured at 570 nm. After treatment, their cell viability was measured. VC exhibited markedly superior inhibitory action compared to THC in MCF-7 cells (p < 0.05); however, in AGS cells, the difference was not statistically significant (p > 0.05), suggesting comparable effects under the evaluated conditions. This shows THC has moderate cytotoxic activity. THC showed a dose-dependent decrease in cell viability and can be selected as a repurposing agent.

Authors

Publication Details

Journal
Cureus
Published
2026-05-21
DOI
https://doi.org/10.7759/cureus.109395
Primary Topic
Natural product bioactivities and synthesis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Anticancer Potential of Thiocolchicoside: An In-Vitro MTT Assay Study

Akash V. Devi, Chitra Khanwelkar
Cureus
Natural product bioactivities and synthesis
article

Anticancer Potential of Thiocolchicoside: An In-Vitro MTT Assay Study

Akash V. Devi, Chitra Khanwelkar
article en

Abstract

Thiocolchicoside (THC), a semi-synthetic derivative of colchicoside, is utilized clinically as a muscle relaxant. Nonetheless, its structural resemblance to colchicine indicates possible anticancer attributes. This study sought to assess the cytotoxic effects of THC on human mammary gland breast adenocarcinoma (MCF-7) and human gastric adenocarcinoma (AGS) cell lines utilizing the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, in comparison to VC. Cells were exposed to incremental dosages of THC 20-100 µg/ml and VC 20-100 µg/ml for 24 to 48 hours, and cell viability was evaluated. THC showed dose‑dependent cytotoxicity, reducing cell viability at higher concentrations, though less potent than VC. These results suggest that THC may have anticancer properties, necessitating more mechanistic and in vivo investigations. The aim was to study the anticancer effects of THC in various cell lines in comparison with the standard drug VC. The MCF-7 and AGS cell lines, which were chosen as exemplary models for the investigation, were procured from the National Centre of Cell Sciences (NCCS), Pune, India. Dimethyl Sulfoxide (DMSO), 200 µl, which was used as a control in this study, was procured from Thermo Fisher, Pune, India. THC was used as a test drug and was procured from Dr. Reddy's Laboratory Limited, Hyderabad, India, and VC, which was used as a reference drug, was procured from Yarrow Chem Products, Mumbai, India. The MTT reagent used in this study to monitor cell viability was procured from Thermo Fisher Scientific, Pune, India. Cell lines were treated with different concentrations of THC and VC ranging from 20 to 100 µg/ml for 24-48 hours, and absorbance was measured at 570 nm. After treatment, their cell viability was measured. VC exhibited markedly superior inhibitory action compared to THC in MCF-7 cells (p < 0.05); however, in AGS cells, the difference was not statistically significant (p > 0.05), suggesting comparable effects under the evaluated conditions. This shows THC has moderate cytotoxic activity. THC showed a dose-dependent decrease in cell viability and can be selected as a repurposing agent.

Cureus
Zero hunger
Openalex Percentile: Top 8%
Natural product bioactivities and synthesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.